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Abstract
Background: The use of cellular and cordless telephones has increased dramatically during the
last decade. There is concern of health problems such as malignant diseases due to microwave
exposure during the use of these devices. The brain is the main target organ.
Methods: Since the second part of the 1990's we have performed six case-control studies on this
topic encompassing use of both cellular and cordless phones as well as other exposures. Three of
the studies concerned brain tumours, one salivary gland tumours, one non-Hodgkin lymphoma
(NHL) and one testicular cancer. Exposure was assessed by self-administered questionnaires.
Results: Regarding acoustic neuroma analogue cellular phones yielded odds ratio (OR) = 2.9, 95
% confidence interval (CI) = 2.0–4.3, digital cellular phones OR = 1.5, 95 % CI = 1.1–2.1 and
cordless phones OR = 1.5, 95 % CI = 1.04–2.0. The corresponding results were for astrocytoma
grade III-IV OR = 1.7, 95 % CI = 1.3–2.3; OR = 1.5, 95 % CI = 1.2–1.9 and OR = 1.5, 95 % CI =
1.1–1.9, respectively. The ORs increased with latency period with highest estimates using > 10
years time period from first use of these phone types. Lower ORs were calculated for astrocytoma
grade I-II. No association was found with salivary gland tumours, NHL or testicular cancer although
an association with NHL of T-cell type could not be ruled out.
Conclusion: We found for all studied phone types an increased risk for brain tumours, mainly
acoustic neuroma and malignant brain tumours. OR increased with latency period, especially for
astrocytoma grade III-IV. No consistent pattern of an increased risk was found for salivary gland
tumours, NHL, or testicular cancer.
Background
During the most recent decades there has been a rapid
development of the use of wireless telephone communi-
cation. The Nordic countries in Europe were among the
first in the world to introduce this new technology.
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The analogue (NMT; Nordic Mobile Telephone System)
phones operating at 450 MegaHertz (MHz) were intro-
duced in Sweden in 1981. In the beginning they were usu-
ally used in a car with fixed external antenna. Portable
NMT 450 phones were introduced in 1984. Analogue
phones using 900 MHz (NMT 900) were used in Sweden
between 1986 and 2000. The digital system (GSM; Global
System for Mobile Communication) started in 1991 and
has during recent years dramatically increased to be the
most common phone type. This system uses dual band,
900 and 1 800 MHz, for communication. From 2003 the
third generation of mobile phones, 3G or UMTS (Univer-
sal Mobile Telecommunication System) has started in
Sweden operating at 1 900 MHz.
Desktop cordless phones also use wireless technology.
First the analogue system in the 800–900 MHz RF was
used when these phones were available in Sweden in
1988. Digital cordless telephones (DECT) that operate at
1900 MHz are used since 1991.
Use of mobile and desktop cellular telephones results in
exposure to microwaves. Exposure is characterized
through the specific absorption rate (SAR) expressed as
watt/kg. The anatomical area with the highest exposure is
the ipsilateral (same) side of the brain that is used during
the call. If a hands-free device is used and the cellular tel-
ephone is placed at another part of the body that anatom-
ical area receives the highest radio frequency (RF)
exposure. The cellular telephone communicates with a
base station usually located at some distance, the antenna
of which typically is on the top of a building or on a mast.
Several workplaces use only cellular or cordless phones
instead of the landline phones and this leads to both
active and passive exposure to microwaves during the
working day for the employees. Very few workplaces offer
hands free devices to the employees although the Nordic
radiation protection authorities as well as the Swedish
work environmental board recommend this.
The introduction of wireless communication has been
technically driven without proper laboratory testing or
epidemiological studies of potential health effects.
Among the first to express concern of adverse health
effects due to exposure to microwaves from cellular
phones was the layman [1]. At that time the technology
was rather new and the use of cell phones was not so wide-
spread. The large expansion has occurred since late
1990's. Now 200 million persons are users in USA and in
Sweden almost everyone has a cellular phone. Thus, even
a health problem of little magnitude would give serious
consequences in the society due to the large number of
exposed persons.
Since the second part of the 1990's we have performed six
case-control studies on this topic encompassing use of
both cellular and cordless phones as well as other expo-
sures. This is an overview of the findings in these studies.
Three of our studies concerned brain tumours. The first
one was rather small [2,3]. This was followed by two
larger case-control studies on brain tumours [4-7]. Here
we present results from the pooled analysis of these two
studies [8,9]. Because of the anatomical localization of
salivary glands, especially the parotid, in an area with high
exposure to microwaves during calls, we performed also a
case-control study on salivary gland tumours [10].
During the same time we studied risk factors for non-
Hodgkin lymphoma (NHL), mainly to elucidate pesticide
exposure as discussed elsewhere [11]. In that study we also
included similar questions on the use of cellular and cord-
less phones [12] as in our at the same time on-going stud-
ies on brain tumours. NHL might be of interest in this
context due to potential effects on the immune system
from microwaves [13,14], since immune modulation is a
risk factor in lymphomagenesis [11]. Also certain cutane-
ous forms of NHL might be of concern due to skin absorp-
tion of microwaves during phone calls.
Finally we have also studied testicular cancer, the main
topic being chemical exposures, e.g., polyvinyl chloride
[15]. The results regarding use of cellular and cordless tel-
ephones have not been published so far. It might be
argued that the testes are at some distance from the cellu-
lar or cordless phone during calls. However, there has
been some concern in the population that keeping the
phone in a pocket might be a risk factor for testicular can-
cer. A recent study found a moderate correlation between
mobile phone use and semen quality [16].
In the following a short description of the studies is given,
further details are displayed in the various publications. In
principle the same epidemiological methods were used in
all studies.
Materials and methods
All studies were performed in Sweden covering various
health service regions and at somewhat different time
periods for recruitment of cases and controls, see Table 1.
The studies on NHL, brain and salivary gland tumours
included both sexes. The Cancer Registries in Sweden were
used to ascertain the cases. The treating physicians were
contacted to get permission to include the cases in the
studies. Deceased cases were excluded from the studies,
mainly patients with malignant brain tumours having a
bad prognosis. The controls were population based drawn
from the Swedish Population Registry covering the whole
country. They were matched on sex, age and geographical
area, i.e., the same geographical area as for the cases in theWorld Journal of Surgical Oncology 2006, 4:74 http://www.wjso.com/content/4/1/74
Page 3 of 10
(page number not for citation purposes)
different investigations. Each study person was given a
unique ID number that did not reveal whether the person
was a case or a control.
Assessment of exposure
All investigations were approved by the responsible ethi-
cal committees and were performed according to the eth-
ical standards laid down by the Helsinki Declaration. All
included persons had the possibility to refuse participa-
tion. Exposures were assessed by mailed questionnaires
and the answers were supplemented over the phone by a
trained interviewer using a structured protocol. The inter-
views as well as coding of the answers for statistical anal-
yses were made blinded as to case or control status.
Details have been further explored in the various publica-
tions. It should be noted that use of cordless phones was
not assessed in our first brain tumour study [2,3].
Statistical analysis
Odds ratios (OR) and 95 % confidence intervals (CI) (SAS
Institute, Cary, NC) were calculated using conditional
logistic regression analysis in the first study on cellular tel-
ephones and brain tumour risk [2,3]. In the following
studies unconditional logistic regression analysis was per-
formed (Stata/SE 8.2 for Windows; StataCorp, College
Station, TX). The unexposed category consisted of subjects
that had not used cellular or cordless phones. The exposed
cases and controls were divided according to phone type,
analogue, digital and cordless. Note that the analyses were
made for those who anytime (disregarding 1 year latency
period) had used an analogue or digital cellular phone or
a cordless phone. However, it is common that many users
have been using all three systems, see further the discus-
sion section. Exposure the year before diagnosis was thus
disregarded in the assessment of exposure. Thereby the
same year for diagnosis of the case was used for the corre-
sponding control as cut-off for exposure. Thus exposure
the year before the diagnosis of the case was also disre-
garded for the control. Adjustment was made for sex, age,
socio-economic index (SEI)-code and year for diagnosis in
the analysis of the two next brain tumour case-control
studies [8,9]. Adjustment for year of diagnosis was made
in order to avoid bias in exposure since all controls both
to malignant and benign brain tumour cases were used in
the analyses. We used age as a continuous variable in the
analysis.
In the study on NHL adjustment was made for age, sex
and year of diagnosis (cases) or enrolment (controls). The
results in the testicular cancer study were adjusted for age
and cryptorchidism.
Latency or tumour induction period was in this presenta-
tion analysed using three time periods, > 1 year, > 5 years
and > 10 years since first use of a cellular or cordless tele-
phone until diagnosis. In the dose-response calculations
median number of cumulative lifetime use in hours
among controls was used as cut-off. Regarding brain
tumours calculation of trend was made dividing cumula-
tive use among the controls in tertiles.
Results
The response rates in the different studies were high, see
Table 1. In the following results for the different diseases
are discussed.
Brain tumours
In our first study no increased risk was found overall, see
Table 2[2]. However, ipsilateral exposure adjusted for
other risk factors, laboratory work and medical diagnostic
X-ray investigations of the head and neck region, yielded
OR 2.6, 95 % CI 1.02–6.7 for brain tumours (benign and
malignant together) in the temporal, occipital or tempo-
roparietal lobes, i.e. most exposed areas [3]. Only 16 cases
had used an analogue cellular phone for > 10 years. Dig-
ital phones had been used by 4 cases with a latency period
> 5 years and no case for > 10 years. Thus, this study was
limited by low numbers of exposed cases and short
latency periods and no firm conclusions could be drawn.
The following two case-control studies on brain tumours
were larger and encompassed answers from 1 254 (88 %)
of cases with benign brain tumour, 905 (90 %) with
malignant brain tumour and 2 162 (89 %) controls. Here
results are given from the pooled analysis of these two
case control studies [8,9]. Detail from the separate studies
can be found elsewhere [4-7].
Regarding meningioma the risk increased with latency
period. With latency > 10 years analogue phones yielded
OR 1.6, 95 % CI 1.04–2.6, digital phones OR 1.8, 95 % CI
0.7–4.6 and cordless phones OR 1.8, 95 % CI 1.01–3.2.
However, in the multivariate analysis adjusted for the dif-
ferent phone types lower ORs were found and no was sta-
tistically significant [8].
All phone types increased the risk for acoustic neuroma.
Regarding analogue phones OR increased with latency
period and was highest in the category with latency period
> 15 years yielding OR = 3.5, 95 % CI = 1.4–10 [8].
Increased risk was also found for digital cellular tele-
phones and cordless phones. However, in the multivariate
analysis only analogue phones were significant risk factors
with OR 2.2, 95 % CI 1.3–3.8 using > 10 year latency
period [8].
In Table 3 results are displayed for use in hours divided in
tertiles based on use among controls. For the whole group
of benign tumours a significant trend was found for total
use in any combination of the different phones. Regard-World Journal of Surgical Oncology 2006, 4:74 http://www.wjso.com/content/4/1/74
Page 4 of 10
(page number not for citation purposes)
ing meningioma no significant trend was found whereas
for acoustic neuroma and the group of other benign
tumours total use yielded a significant trend.
For astrocytoma grade I-II there was no clear trend of
increasing OR with increasing latency period, see Table 2.
Cordless phones yielded OR 1.9 of borderline significance
with latency > 5 years but OR did not increase further with
latency > 10 years and was not statistically significant in
that group.
On the contrary, for astrocytoma grade III-IV OR
increased with latency period and was highest using > 10
year latency for all phone types. In that latency group mul-
tivariate analysis yielded for analogue phones OR 2.0, 95
% CI 1.4–2.9, digital phones OR 2.4, 95 % CI 1.1–4.9 and
cordless phones OR 1.3, 95 % CI 0.8–2.3 [9].
Trend test gave for all malignant tumours together and
astrocytoma grade III-IV a significant result for cordless
phones and total use in any combination of the different
phone types, see Table 4. No significant trend was
obtained for astrocytoma grade I-II or other types of
malignant tumours.
Many people in the study had been using all three types of
phones: NMT, GSM and cordless. The most obvious com-
bination of the use of different phones is to add the total
time on each phone without setting different weight to
each of them. However, the different phone types have
different output power. The NMT phone is operating with
a maximum power of 1 W and very seldom down regu-
lates this; the GSM 900 phone is operating with a maxi-
mum of 0.25 W but can down regulate the power to a few
mW depending on the distance to the base station, and a
typical value would be 0.1 W; the cordless phones operate
at 10 mW. One selection of weighting factors according to
mean output power of the phones could then be NMT =
1, GSM = 0.1, and cordless = 0.01 [17,18]. These factors
have been used in Table 5 where the time spent on each of
the phone types has been multiplied with these factors
before adding them into one score using data in our sec-
ond brain tumour study [4,5]. The results differ depend-
ing on how the combination is done, but not so much.
The main trend with an increased risk with increased hour
of use is also seen in these calculations, obvious in the >
10 year latency group [18].
In Table 6 results are presented for ipsilateral exposure
using > 1 year latency period. Highest ORs were found for
acoustic neuroma and astrocytoma grade III-IV for both
cellular and cordless desktop phones. Digital mobile
phones yielded for meningioma and astrocytoma grade I-
II increased OR of borderline significance. Also cordless
phones gave for astrocytoma grade I-II increased OR of
borderline significance.
Salivary gland tumours
No association between use of cellular or cordless phones
and salivary gland tumours was found [10]. The results
were limited due to few cases with long-term use of the
phone types. Only 6 cases had used an analogue phone >
10 years and no one had used a digital or cordless phone
using that latency period. Thus, further studies would be
necessary to make definitive conclusions regarding an
association. No significantly increased OR was found for
ipsilateral exposure, Table 6.
Non-Hodgkin lymphoma (NHL)
No association was found with B-cell NHL [12]. Regard-
ing T-cell NHL OR increased with latency period for dig-
ital and cordless phones. Latency period > 5 years for use
of analogue cellular phones yielded OR = 1.5, 95 % CI =
0.6–3.7, digital OR = 1.9, 95 % CI = 0.8–4.8, and cordless
Table 1: Description of studies by Hardell et al on use of cellular and cordless telephones and the risk for tumour diseases.
Study Geographical area Years Included persons Response rate
CNS [2,3] Uppsala/Örebro
Stockholm
1994–1996
1995–1996
233 cases*
466 controls
209 (90%) cases
425 (91%) controls
CNS [4,5] Uppsala/Örebro, Stockholm, 
Linköping, Göteborg
Jan 1, 1997 – June 30, 2000 1617 cases
1617 controls
1429 (88%) cases
1470 (91 %) controls
CNS, benign [6] Uppsala/Örebro, Linköping July 1, 2000 – Dec 31, 2003 462 cases**
820 controls
413 (89 %) cases
692 (84 %) controls
CNS, malignant [7] Uppsala/Örebro, Linköping July 1, 2000 – December 31, 2003 359 cases**
820 controls
317 (88 %) cases
692 (84 %) controls
Salivary gland tumours [10] Stockholm, Linköping
Uppsala/Örebro
Umeå, Göteborg, Lund
Jan 1, 1994 – Dec 31, 1999
Jan 1, 1994 – June 30, 2000
Jan 1, 1994 – June 30, 1999
293 cases
1172 controls
267 (91%) cases
1053 (90%) controls
Non-Hodgkin lymphoma [11] Umeå, Örebro, Linköping, Lund Dec 1, 1999 – April 30, 2002 995 cases
1108 controls
910 (91%) cases
1016 (92%) controls
Testicular cancer Hardell et al to 
be published
Whole Sweden 1993 – 1997 981 cases
981 controls
889 (91%) cases
870 (89%) controls
* One case had two benign brain tumours.
** One case had both a malignant and a benign brain tumourWorld Journal of Surgical Oncology 2006, 4:74 http://www.wjso.com/content/4/1/74
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phones OR = 2.5, CI = 1.1–5.6. The corresponding results
for extranodal T-cell lymphoma were for analogue phones
OR = 3.4, 95 % CI = 0.8–15.0, digital OR = 6.1, 95 % CI =
1.3–29.7 and cordless phones OR = 5.5, 95 % CI = 1.3–
23.9.
Testicular cancer
Results from this study have so far only been published
for exposure to polyvinyl chloride, which was the main
issue of the study [15]. Questions on use of cellular and
cordless phones were also included in the questionnaire
in the similar way as in the other studies above. However,
this time we also included questions on where the cellular
phone usually was kept between calls. We asked if the
phone was on stand-by during that time. The results were
based on answers from 542 (92 %) cases with seminoma,
346 (89 %) with non-seminoma and 870 (89 %) controls.
Regarding seminoma use of analogue cellular phones
gave OR = 1.2, 95 % CI = 0.9–1.6, digital phones OR = 1.3,
CI = 0.9–1.8, and cordless phones OR = 1.1, CI = 0.8–1.5.
The corresponding results for non-seminoma were OR =
0.7, CI = 0.5–1.1, OR = 0.9, CI = 0.6–1.4, and OR = 1.0,
CI = 0.7–1.4, respectively. A somewhat increased OR was
found for seminoma and use of analogue phones in the
group with > 5 year latency period yielding OR = 1.5, 95
% CI = 0.98–2.2 and for digital phones with OR = 4.1, 95
% CI = 0.97–17, and cordless phones OR = 1.2, 95 % CI
= 0.7–1.9. Regarding non-seminoma digital phones
yielded in the same category OR = 2.3, 95 % CI = 0.5–12
whereas OR for analogue cellular phones and cordless
phones was close to unity. No association was found with
place of keeping the mobile phone during stand-by, such
as trousers pocket. Cryptorchidism was a risk factor for
Table 2: Use of cellular and cordless phones and odds ratio (OR) and 95 % confidence intervals (CI) for different tumour types.
> 1 year latency > 5 years latency > 10 years latency
Study, period Analogue
OR
CI
Digital
OR
CI
Cordless
OR
CI
Analogue
OR
CI
Digital
OR
CI
Cordless
OR
CI
Analogue
OR
CI
Digital
OR
CI
Cordless
OR
CI
CNS 1994–1996 [2,3]
-All 0.9
0.6–1.4
1.0
0.6–1.5
NA 0.8
0.5–1.4
0.3
0.03–2.1
NA 1.2
0.6–2.6
-* NA
CNS 1997–2003 [8,9]
-All 1.5
1.3–1.9
1.2
1.03–1.4
1.3
1.1–1.5
1.7
1.3–2.1
1.6
1.2–2.0
1.6
1.3–1.9
2.2
1.6–3.0
2.8
1.5–5.3
1.9
1.2–2.9
-Benign, all 1.6
1.3–2.0
1.2
0.96–1.4
1.2
1.01–1.4
1.7
1.3–2.3
1.3
0.99–1.8
1.5
1.2–1.9
1.9
1.3–2.8
2.2
0.99–4.9
1.6
0.9–2.7
-Meningoma 1.3
0.99–1.7
1.1
0.9–1.3
1.1
0.9–1.4
1.3
0.98–1.8
1.2
0.9–1.7
1.5
1.1–1.9
1.6
1.04–2.6
1.8
0.7–4.6
1.8
1.01–3.2
-Acoustic neuroma 2.9
2.0–4.3
1.5
1.1–2.1
1.5
1.04–2.0
3.2
2.0–4.9
1.6
0.9–2.8
1.6
1.02–2.6
3.2
1.7–6.1
0.8
0.1–6.6
1.3
0.4–3.8
-Malignant, all 1.5
1.1–1.9
1.3
1.1–1.6
1.3
1.1–1.6
1.6
1.2–2.1
1.8
1.3–2.4
1.6
1.2–2.1
2.4
1.7–3.5
3.4
1.6–7.3
2.1
1.2–3.5
-Astrocytoma, grade I-II 1.2
0.6–2.2
1.4
0.9–2.3
1.4
0.9–2.3
1.1
0.5–2.3
1.5
0.7–3.3
1.9
1.03–3.5
1.5
0.6–4.1
1.3
0.1–13
1.8
0.6–5.9
-Astrocytoma, grade III-IV 1.7
1.3–2.3
1.5
1.2–1.9
1.5
1.1–1.9
1.9
1.4–2.7
2.5
1.7–3.5
2.1
1.5–2.9
3.0
2.0–4.6
5.2
2.2–12
2.7
1.5–5.0
Salivary gland tumours 1994–1999 [10]
-All 0.9
0.6–1.4
1.0
0.7–1.5
1.0
0.7–1.4
0.8
0.4–1.4
1.2
0.5–2.8
1.1
0.6–2.0
0.7
0.3–1.7
-* -*
Non-Hodgkin lymphoma 1999–2002 [11]
-B-cell 0.9
0.7–1.3
1.0
0.8–1.3
1.0
0.8–1.3
1.0
0.7–1.4
0.9
0.7–1.3
1.0
0.7–1.3
1.0
0.7–1.4
1.1
0.4–3.3
1.1
0.6–1.8
-T-cell 1.6
0.6–3.8
1.4
0.7–2.9
1.4
0.6–2.9
1.5
0.6–3.7
1.9
0.8–4.8
2.5
1.1–5.6
1.5
0.5–4.3
3.0
0.3–34
3.2
1.05–9.5
Testicular cancer Hardell et al, to be 
published 1993–1997
-All 1.0
0.8–1.3
1.2
0.9–1.6
1.1
0.8–1.4
1.2
0.9–1.8
3.4
0.9–13
1.1
0.7–1.6
1.6
0.7–3.8
-* -*
-Seminoma 1.2
0.9–1.6
1.3
0.9–1.8
1.1
0.8–1.5
1.5
0.98–2.2
4.1
0.97–17
1.2
0.7–1.9
2.1
0.8–5.0
-* -*
-Non-seminoma 0.7
0.5–1.1
0.9
0.6–1.4
1.0
0.7–1.4
0.9
0.5–1.6
2.3
0.5–12
0.9
0.5–1.6
0.3
0.04–2.7
-* -*
Results are given for different latency periods.
*No exposed cases.
NA = not assessedWorld Journal of Surgical Oncology 2006, 4:74 http://www.wjso.com/content/4/1/74
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both seminoma and non-seminoma, but no interaction
with cellular or cordless phones was found.
Discussion
The same study methods were used in all these case-con-
trol studies performed by our research group. The results
varied for different tumour types and would thus not be
expected to be caused by observational or recall bias since
such bias should have existed for all tumour types. More-
over the results seem to be of biological relevance regard-
ing tumour type, tumour localisation, latency period and
dose-response effect.
Cases were ascertained from the Swedish Cancer Registry
that has a good coverage of all new cases. Controls were
enrolled from the Swedish Population Registry that covers
the whole population. All subjects in Sweden have a
unique id-number. Thus, no selection bias was introduced
in the enrolment of cases and controls in the various stud-
ies. The population registry also makes it possible to find
the address of all included subjects so no case or control
was excluded due to lack of address for mailing of the
questionnaire. It should however be noted that only living
cases were included in the studies. Of brain tumours
glioblastoma multiforme has a bad prognosis. This may
have shifted the distribution of histopathological types of
cases to slightly better prognosis. The influence on the
results, if any, is currently unknown.
Regarding brain tumours assessment of exposure was
made about two months after histopathological diagno-
sis. One advantage was that the cases were informed about
their diagnoses and that the cases could answer to the
questionnaires and phone interviews at home in a more
relaxed setting than in a hospital. When supplementing
the data in the questionnaires over the phone it was not
revealed if it was a case or a control. The coding of the data
for statistical analysis was made without knowing the
identity of the subject. Thus, observational bias was
avoided in the studies.
Table 3: Odds ratio (OR) and 95 % confidence interval (CI) for cumulative lifetime use in hours of analogue and digital cellular 
telephones, cordless telephones and any combination of the three phone types for benign brain tumours [8].
First tertile (h) Second tertile (h) Third tertile (h)
Ca/Co OR 95 % CI Ca/Co OR 95 % CI Ca/Co OR 95 % CI
Benign
Analogue 77/109 1.5 1.1–2.1 51/89 1.4 0.97–2.1 71/99 1.9 1.3–2.7
Digital 175/283 1.2 0.9–1.5 141/246 1.2 0.9–1.5 121/247 1.1 0.9–1.5
Cordless 146/264 1.1 0.9–1.4 108/204 1.1 0.8–1.4 169/233 1.5 1.2–1.9
Total, any combination 238/405 1.1 0.9–1.4 187/377 1.0 0.8–1.2 252/390 1.4 1.1–1.7
Meningioma
Analogue 47/109 1.3 0.9–1.9 32/89 1.3 0.8–2.0 34/99 1.3 0.9–2.1
Digital 116/283 1.0 0.8–1.3 106/246 1.2 0.9–1.6 73/247 1.0 0.7–1.4
Cordless 106/264 1.1 0.8–1.4 70/204 0.9 0.7–1.3 118/233 1.4 1.1–1.9
Total, any combination 163/405 1.0 0.8–1.3 136/377 1.0 0.8–1.2 162/390 1.2 0.96–1.6
Acoustic neuroma
Analogue 20/109 2.3 1.3–4.0 18/89 2.7 1.5–4.9 30/99 4.1 2.4–7.0
Digital 42/283 1.7 1.1–2.5 26/246 1.2 0.7–1.9 37/247 1.7 1.03–2.7
Cordless 27/264 1.1 0.7–1.8 29/204 1.5 0.95–2.5 40/233 1.8 1.2–2.8
Total, any combination 46/405 1.3 0.9–1.9 40/377 1.2 0.8–1.8 69/390 2.0 1.4–3.0
Other benign
Analogue 10/109 2.5 1.2–5.5 2/89 0.5 0.1–2.1 7/99 1.7 0.7–4.2
Digital 17/283 2.1 1.1–3.9 10/246 1.2 0.5–2.6 11/247 1.0 0.4–2.1
Cordless 13/264 1.4 0.7–2.8 9/204 1.4 0.6–3.2 12/233 1.5 0.7–3.1
Total, any combination 29/405 2.1 1.2–3.5 11/377 0.8 0.4–1.7 22/390 1.5 0.8–2.7
Number of exposed cases (Ca) and controls (Co) are given. Unconditional logistic regression analysis adjusted for age, sex, socio-economic index 
and year of diagnosis was used. Tertiles were based on use among controls.
Trend, benign: Analogue – p = 0.42, digital – p = 0.97, cordless – p = 0.06, total – p = 0.02.
Trend, meningioma: Analogue – p = 0.99, digital – p = 0.40, cordless – p = 0.07, total – p = 0.18.
Trend, acoustic neuroma: Analogue – p = 0.17, digital – p = 0.31, cordless – p = 0.18, total – p = 0.02.
Trend, other benign: Analogue – p = 0.11, digital – p = 0.16, cordless – p = 0.98, total – p = 0.047.
Analogue: First tertile – 1–43 h, second tertile – >43–165 h, third tertile – >165 h
Digital: First tertile – 1–30 h, second tertile – >30–149 h, third tertile – >149 h
Cordless: First tertile – 1–122 h, second tertile – >122–365 h, third tertile – >365 h
Total, any combination: First tertile – 1–91 h, second tertile – >91–410 h, third tertile – >410 hWorld Journal of Surgical Oncology 2006, 4:74 http://www.wjso.com/content/4/1/74
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In the brain tumour studies we found the highest OR for
acoustic neuroma. This tumour might be a "signal"
tumour type for increased brain tumour risk from micro-
wave exposure, since it is located in an anatomical area
with high exposure during calls with cellular or cordless
phones. In fact, an increasing incidence of acoustic neu-
roma has been noted in Sweden [19]. For both analogue
cellular telephones and cordless desktop phones the risk
was highest in the third tertile of use in hours. However,
no such trend was seen for digital phones. For all phones
combined we found a significant trend of OR with
increasing time for use, p = 0.02.
Regarding meningioma no significant trend was found.
Cordless phones produced highest OR in the third tertile
of borderline significance. For use of any phone no signif-
icantly increased risk was found. OR was highest for other
types of benign tumours in the first tertile for use of ana-
logue or digital phones. For cordless phones the OR was
similar in all three categories of use. Thus, the results for
other types of benign brain tumours indicate that there is
no association and that longer follow-up time is needed
for evaluation of long-term effects.
For astrocytoma grade I-II highest OR was calculated in
the third tertile of use in hours, see Table 4. ORs were sta-
tistically significantly increased for cordless phones and
total use in any combination. The trend tests of these cat-
egories of exposure were not significant, however.
Regarding astrocytoma grade III-IV significantly increased
risks were found in the highest exposure category, see
Table 4. As presented elsewhere [9] both analogue and
digital cellular telephones were statistically significant risk
factors in the multivariate analysis. However, in the trend
test of cumulative use the result was statistically signifi-
cant only for cordless telephones and total use of all
phone types together, see Table 4.
Adaptive power control (APC) gives a difference in power
output from mobile phones between urban and rural
areas due to regulations of the emissions by the distance
Table 4: Odds ratio (OR) and 95 % confidence interval (CI) for cumulative lifetime use in hours of analogue and digital cellular 
telephones, cordless telephones and any combination of the three phone types for malignant brain tumours [9].
First tertile (h) Second tertile (h) Third tertile (h)
Ca/Co OR 95 % CI Ca/Co OR 95 % CI Ca/Co OR 95 % CI
Malignant
Analogue 57/109 1.4 0.97–2.0 41/89 1.1 0.7–1.7 80/99 1.9 1.3–2.7
Digital 133/283 1.3 1.03–1.7 108/246 1.1 0.9–1.5 161/247 1.5 1.1–1.9
Cordless 107/264 1.1 0.8–1.4 94/204 1.2 0.9–1.6 149/233 1.7 1.3–2.3
Total, any combination 170/405 1.2 0.9–1.5 169/377 1.2 0.9–1.5 244/390 1.5 1.2–1.9
Astrocytoma, grade I-II
Analogue 5/109 0.9 0.3–2.4 7/89 1.4 0.6–3.5 7/99 1.3 0.5–3.3
Digital 20/283 1.6 0.9–2.9 12/246 1.0 0.5–2.0 24/247 1.6 0.8–2.9
Cordless 15/264 1.2 0.6–2.2 13/204 1.1 0.5–2.2 28/233 1.9 1.1–3.5
Total, any combination 25/405 1.4 0.8–2.4 22/377 1.1 0.6–2.0 41/390 1.7 1.04–2.9
Astrocytoma, grade III-IV
Analogue 34/109 1.5 0.99–2.4 27/89 1.3 0.8–2.2 54/99 2.3 1.5–3.5
Digital 74/283 1.4 1.01–1.9 71/246 1.4 1.02–2.0 99/247 1.8 1.3–2.5
Cordless 65/264 1.2 0.8–1.6 50/204 1.3 0.9–1.9 90/233 2.1 1.5–2.9
Total, any combination 91/405 1.1 0.8–1.5 104/377 1.4 1.03–1.8 146/390 1.8 1.3–2.4
Other malignant
Analogue 18/109 1.5 0.8–2.6 7/89 0.7 0.3–1.7 19/99 1.6 0.9–3.0
Digital 39/283 1.4 0.9–2.1 25/246 0.9 0.5–1.4 38/247 1.1 0.7–1.8
Cordless 27/264 1.0 0.6–1.6 31/204 1.3 0.8–2.1 31/233 1.2 0.8–1.9
Total, any combination 54/405 1.4 0.9–2.0 43/377 1.1 0.7–1.6 57/390 1.3 0.9–1.9
Number of exposed cases (Ca) and controls (Co) are given. Unconditional logistic regression analysis adjusted for age, sex, socio-economic index 
and year of diagnosis was used. Tertiles were based on use among controls.
Trend, malignant: Analogue – p = 0.11, digital – p = 0.21, cordless – p = 0.01, total – p = 0.04.
Trend, astrocytoma, grade I-II: Analogue – p = 0.72, digital – p = 0.38, cordless – p = 0.16, total – p = 0.30.
Trend, astrocytoma, grade III-IV: Analogue – p = 0.10, digital – p = 0.26, cordless – p = 0.01, total – p = 0.01.
Trend, other malignant: Analogue – p = 0.21, digital – p = 0.23, cordless – p = 0.64, total – p = 0.50.
Analogue: First tertile – 1–43 h, second tertile – >43–165 h, third tertile – >165 h
Digital: First tertile – 1–30 h, second tertile – >30–149 h, third tertile – >149 h
Cordless: First tertile – 1–122 h, second tertile – >122–365 h, third tertile – >365 h
Total, any combination: First tertile – 1–91 h, second tertile – >91–410 h, third tertile – >410 hWorld Journal of Surgical Oncology 2006, 4:74 http://www.wjso.com/content/4/1/74
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to the base stations. The place of residence for the cases
and controls in our second brain tumour study [4,5] was
divided in groups based on population density using Sta-
tistics Sweden [20]. A clear effect was seen for digital
phone users with highest risk in rural areas, OR = 3.2, 95
% CI = 1.2–8.4, compared with in urban areas OR = 0.9,
95 % CI = 0.6–1.4, using > 5 year latency period. The
power output is highest in rural areas so the results indi-
cate a dose-response effect. For analogue phones no such
pattern was found that might be explained by the fact that
APC has not previously been used for analogue phones.
The same study method as in the brain tumour studies
was used for salivary gland tumours [10]. We did not find
an association between use of cellular or cordless tele-
phones and salivary gland tumours in this study. There
was no effect with increasing tumour induction period or
number of hours of use of the different phones. However,
only 6 cases had used a phone for more than 10 years, and
all of these subjects had used the analogue type. Thus, this
study cannot exclude an increased risk among subjects
with heavy use for a long time period. The power of the
study was to detect an OR ≥ 1.4 (α = 0.05, β = 0.20). This
case-control study was performed during the same time
period as our brain tumour studies. These results strongly
argue against observational and recall bias as the explana-
tion for our results in the brain tumour studies. A recent
study did not find an association between mobile phone
use and parotid gland tumour regardless of duration of
use in hours or years since first use [21].
The results in our case-control study on NHL are of poten-
tial interest [11]. We found no association with B-cell lym-
phoma whereas the findings for T-cell NHL may be of
Table 5: Odds ratio (OR) and 95 % confidence interval (CI) for brain tumours [4,5].
> 1 year latency > 5 years latency > 10 years latency
Score Ca/Co OR 95 % CI Score Ca/Co OR 95 % CI Score Ca/Co OR 95 % CI
Total 716/713 1.1 0.9 – 1.3 Total 321/272 1.3 1.1 – 1.6 Total 69/51 1.6 1.1 – 2.3
≤ 11.0 350/357 1.0 0.9 – 1.3 ≤ 46.8 167/136 1.3 1.04 – 1.7 ≤ 166 29/26 1.2 0.7 – 2.1
> 11.0 366/356 1.1 0.9 – 1.3 > 46.8 154/136 1.3 0.98 – 1.7 > 166 40/25 1.9 1.1 – 3.3
Score by multiplying weighting factors, analogue= 1, digital = 0.1, cordless telephone = 0.01, with cumulative use in hours for the different phone 
types and adding all three categories was used. Unconditional logistic regression analysis adjusted for age, gender and socioeconomic index was 
used. Unexposed groups were used for comparison. Median score among the controls for each latency period used as cut-off. Number of cases 
(Ca) and controls (Co) is given.
Table 6: Odds ratio (OR) and 95 % confidence interval (CI) for ipsilateral use of mobile (analogue, digital) or cordless phones.
Ipsilateral
Study, period Analogue
OR
CI
Digital
OR
CI
Cordless
OR
CI
CNS 1997–2003 [8,9]
-All 2.0
1.5–2.6
1.6
1.3–2.0
1.5
1.2–1.9
-Benign, all 1.9
1.3–2.6
1.5
1.1–1.9
1.4
1.1–1.8
-Meningioma 1.3
0.9–2.0
1.4
1.01–1.8
1.3
0.9–1.7
-Acoustic neuroma 3.0
1.9–5.0
1.7
1.1–2.6
1.7
1.1–2.6
-Malignant, all 2.1
1.5–2.9
1.8
1.4–2.4
1.7
1.3–2.2
-Astrocytoma, grade I-II 1.8
0.8–4.1
1.9
1.02–3.5
1.9
1.05–3.5
-Astrocytoma, grade III-IV 2.4
1.6–3.6
2.3
1.7–3.1
2.0
1.5–2.8
Salivary gland tumours 1994–1999 [10]
-All 1.4
0.8–2.6
1.2
0.7–2.0
1.0
0.6–1.7
Results are presented for brain tumours [8,9] and salivary gland tumours [10] using > 1 year latency period.World Journal of Surgical Oncology 2006, 4:74 http://www.wjso.com/content/4/1/74
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importance. Analysing the cutaneous and leukaemia types
of T-cell NHL increased the risk further. T-cell NHL is
uncommon and represented 5.8 % in our study. T-cell
lymphomas are derived from mature or post-thymic circu-
lating T-cells. Exposure to microwaves may occur in the
circulating blood during a phone call. Our results were
based on low numbers and must be interpreted with cau-
tion. There is no obvious biological mechanism that
explains the results and further studies are therefore nec-
essary.
The main result of the study on testicular cancer was no
association with use of cellular or cordless telephones
[Hardell et al, to be published]. For seminoma signifi-
cantly increased OR was calculated in lowest exposure cat-
egory with > 1 year latency period for all studied phone
types. However, there was no dose-response effect and no
significant trend for increasing OR with increasing latency
period. As one would expect cryptorchidism was associ-
ated with increased risk for both seminoma and non-sem-
inoma but did not interact with use of cellular or cordless
phones. The localization of the mobile phone during
stand-by time was also analyzed. However, no association
was found with testicular cancer. Keeping the phone in a
pocket close to the testis did not increase the risk and there
was no association with laterality of the phone and can-
cer.
In studies of tumour risk and mobile phone use exposure
assessment becomes an even greater problem than for the
acute effects since for this type of disease it is the exposure
5–10 years or more ago that is of interest. Most users of
mobile phones have not been using just one single tele-
phone. It is even more likely that if they have been using
a mobile phone for more than a few years, they will also
have changed their phone a few times. Many users will
also have used different phone systems such as analogue
and digital, and probably many of them have also been
using a cordless phone at home or at work. The problem
we are facing is then how to integrate the various SAR dis-
tributions from the different devices and add up the differ-
ent times on these phones to one exposure measure? At
the moment it is not clear how to combine the use of dif-
ferent phones with different power output, different sys-
tems, different frequencies, and different anatomical SAR
distribution, into one exposure and dose measure. The
difficulties lay in the fact that we do not know the interact-
ing mechanism(s) between the electromagnetic fields
emitted from the phone and the biological organism.
We used a weighting method as described above to com-
bine exposure measurement from different phone types;
NMT = 1, GSM = 0,1 and cordless phones = 0.01. This
method was applied for data in our second brain tumour
study [4,5] and has been discussed elsewhere [17,18]. The
results did not differ much from using no weighting fac-
tor. This could be due to the large weight put to the NMT
phone due to their high output power. On theoretical
ground, using the sum of the use in hours of the different
phone types is obviously not an appropriate method
when combining exposure to these radio frequency (RF)
fields. Using a weighting factor might be appropriate until
a proper dosimetry is available.
In future epidemiological studies on brain tumours an
important consideration ought to be which time scale to
use, and this must be based on hypotheses about induc-
tion and progression of the endpoint variables being stud-
ied. One needs to set up a clear hypothesis about how the
absorption to RF from mobile phones could influence the
endpoint variable in terms of anatomical localization of
the absorption, the duration of the exposure and the
induction and progression of the endpoint variable before
choosing an appropriate dosimetric quantity.
One of the questions we need to address is for instance
how time comes into the connection between exposure
and dose, and here we need to distinguish between differ-
ent aspects of time: very short times – order of minutes,
daily averages, and total time in the actual occupation –
number of years with exposure. Another question that is
urgent to address is the potential for greater biological
effects from RF fields in young age groups. We have found
some indication for that with higher risk for brain
tumours in persons with first use of cellular or cordless
phones before the age of 20 years compared with older
ages [8,9,22].
Conclusion
We have here presented results from our studies on this
topic. The intention was not to cover the whole area, such
presentations can be found in other publications [23-25].
In our series of studies on tumour risk associated with use
of cellular or cordless telephones the consistent finding
for all studied phone types was an increased risk for brain
tumours, mainly acoustic neuroma and malignant brain
tumours. Using a latency period of > 10 years ORs
increased especially for astrocytoma grade III-IV. No con-
sistent pattern of an increased risk was found for salivary
gland tumours, NHL or testicular cancer.
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